Haemonetics Corp (HAE US)

Analysis

Health Care • United States

Haemonetics Corporation designs, manufactures, and markets automated blood processing systems. The Company's products are for use in surgical blood salvage, blood component collections, and plasma collections. Haemonetics markets its products worldwide, primarily outside the United States.

Refresh

Company Event • 05 Nov 2026 21:00 • Upcoming

Add To Calendar

Q2 2027

Company Event • 06 Aug 2026 20:00 • Latest

Q1 2027

Company Event • 09 Jun 2026 20:00 • Upcoming

Add To Calendar

Proxy filing

Company Event • 09 Jun 2026 20:00 • Upcoming

Add To Calendar

Proxy filing

Company Event • 09 Jun 2026 04:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Q2 2027

Q1 2027

Proxy filing

Proxy filing

Goldman Sachs 47th Annual Global Healthcare Conference 2026